U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.2963G>A (p.Trp988Ter) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 4, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001941571.6

Allele description [Variation Report for NM_000138.5(FBN1):c.2963G>A (p.Trp988Ter)]

NM_000138.5(FBN1):c.2963G>A (p.Trp988Ter)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.2963G>A (p.Trp988Ter)
HGVS:
  • NC_000015.10:g.48489970C>T
  • NG_008805.2:g.160819G>A
  • NM_000138.5:c.2963G>AMANE SELECT
  • NP_000129.3:p.Trp988Ter
  • LRG_778t1:c.2963G>A
  • LRG_778:g.160819G>A
  • NC_000015.9:g.48782167C>T
  • NM_000138.4:c.2963G>A
Protein change:
W988*
Links:
dbSNP: rs2043543553
NCBI 1000 Genomes Browser:
rs2043543553
Molecular consequence:
  • NM_000138.5:c.2963G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfan syndrome type 1; Marfan's syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700
Name:
Familial thoracic aortic aneurysm and aortic dissection (TAAD)
Synonyms:
Thoracic aortic aneurysm and aortic dissection; Thoracic aortic aneurysms and dissections
Identifiers:
MONDO: MONDO:0019625; MedGen: C4707243; Orphanet: 91387; OMIM: PS607086

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002228192Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 4, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

[Clinical and Genetic Characteristics of Russian Marfan Patients].

Semyachkina AN, Adyan TA, Khabadze MN, Novikov PV, Polyakov AV.

Genetika. 2015 Jul;51(7):812-20. Russian.

PubMed [citation]
PMID:
26410935

Identification of FBN1 gene mutations in Ukrainian Marfan syndrome patients.

Zhurayev R, Proost D, Zerbino D, Fedorenko V, Meester JA, VAN Laer L, Loeys BL.

Genet Res (Camb). 2016 Oct 11;98:e13.

PubMed [citation]
PMID:
27724990
PMCID:
PMC6865158
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002228192.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individuals with Marfan syndrome (PMID: 26410935, 27724990). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp988*) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024